Edwin Rock, Chief Medical Officer at GLYCOMIMETICS INC (GLYC), bought 305,000 shares at $0.25 ($79K) on 2024-06-20, disclosed to the SEC on 2024-06-24.
Open-market purchase of $79k GLYC by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 190,000 | $48K | 60.5% |
| 2 | $0.27 | 115,000 | $31K | 39.5% |
| Total | $0.26 avg | 305,000 | $79K | 100% |
| Filing → |
| GLYC | BUY | 2022-11-16 | $309K | — | Filing → |